Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Alcidion Group Limited ( (AU:ALC) ) has issued an update.
Alcidion Group Limited has announced a revision to its Securities Trading Policy in compliance with ASX Listing Rule 12.10. This update is part of the company’s ongoing efforts to maintain robust corporate governance practices. The revised policy is available on Alcidion’s website, reflecting the company’s commitment to transparency and regulatory compliance, which is crucial for its stakeholders and market positioning.
The most recent analyst rating on (AU:ALC) stock is a Buy with a A$0.09 price target. To see the full list of analyst forecasts on Alcidion Group Limited stock, see the AU:ALC Stock Forecast page.
More about Alcidion Group Limited
Alcidion Group Limited is a company focused on transforming healthcare through innovative technology solutions that enhance the efficiency and quality of patient care globally. The company offers a range of software products and technical services, with its flagship product, Miya Precision, providing centralized dashboards, interoperability support, communication facilitation, and clinical decision support. Alcidion has expanded its presence in the UK, Australia, and New Zealand, servicing over 400 hospitals and 87 healthcare organizations.
Average Trading Volume: 1,473,360
Technical Sentiment Signal: Buy
Current Market Cap: A$161.2M
For a thorough assessment of ALC stock, go to TipRanks’ Stock Analysis page.